Regeneron Intrinsic
Value
As of 2024-12-14, the Intrinsic Value of Regeneron Pharmaceuticals Inc (REGN) is
625.22 USD. This Regeneron valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 731.30 USD, the upside of Regeneron Pharmaceuticals Inc is
-14.50%.
The range of the Intrinsic Value is 455.11 - 1,033.32 USD
625.22 USD
Intrinsic Value
Regeneron Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
455.11 - 1,033.32 |
625.22 |
-14.5% |
| DCF (Growth 10y) |
518.75 - 1,103.02 |
692.36 |
-5.3% |
| DCF (EBITDA 5y) |
573.58 - 1,092.52 |
726.60 |
-0.6% |
| DCF (EBITDA 10y) |
636.86 - 1,211.39 |
811.15 |
10.9% |
| Fair Value |
1,058.90 - 1,058.90 |
1,058.90 |
44.80% |
| P/E |
573.47 - 660.75 |
630.34 |
-13.8% |
| EV/EBITDA |
483.95 - 937.66 |
630.94 |
-13.7% |
| EPV |
398.33 - 527.87 |
463.10 |
-36.7% |
| DDM - Stable |
360.54 - 1,094.99 |
727.76 |
-0.5% |
| DDM - Multi |
390.35 - 926.83 |
549.93 |
-24.8% |
Regeneron Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
80,362.55 |
| Beta |
0.78 |
| Outstanding shares (mil) |
109.89 |
| Enterprise Value (mil) |
81,054.76 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.85% |
| Cost of Debt |
4.25% |
| WACC |
9.66% |